These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28109741)

  • 21. Severe vancomycin-induced anaphylactic reaction.
    Kupstaite R; Baranauskaite A; Pileckyte M; Sveikata A; Kadusevicius E; Muckiene G
    Medicina (Kaunas); 2010; 46(1):30-3. PubMed ID: 20234160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin-Associated Acute Kidney Injury in a Large Veteran Population.
    Gyamlani G; Potukuchi PK; Thomas F; Akbilgic O; Soohoo M; Streja E; Naseer A; Sumida K; Molnar MZ; Kalantar-Zadeh K; Kovesdy CP
    Am J Nephrol; 2019; 49(2):133-142. PubMed ID: 30677750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
    Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Culos KA; Cannon JP; Grim SA
    Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute Kidney Injury: A Case Report].
    Sakai Y; Miwa R; Mitsuoka M; Watanabe H
    Yakugaku Zasshi; 2020; 140(5):751-754. PubMed ID: 32378679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
    Ramírez E; Jiménez C; Borobia AM; Tong HY; Medrano N; Krauel-Bidwell L; Carcas AJ; Selgas R; Frías J
    Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a trough-only extrapolated area under the curve vancomycin dosing method on clinical outcomes.
    Lines J; Burchette J; Kullab SM; Lewis P
    Int J Clin Pharm; 2021 Feb; 43(1):263-269. PubMed ID: 32964405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.
    van Hal SJ; Paterson DL; Lodise TP
    Antimicrob Agents Chemother; 2013 Feb; 57(2):734-44. PubMed ID: 23165462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management.
    Changela A; Javaiya H; Rickenback K; Elnawawi A; Changela K
    Am J Ther; 2013; 20(2):223-5. PubMed ID: 21273948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vancomycin: we can't get there from here.
    Patel N; Pai MP; Rodvold KA; Lomaestro B; Drusano GL; Lodise TP
    Clin Infect Dis; 2011 Apr; 52(8):969-74. PubMed ID: 21460308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
    Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
    J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
    Sipahi OR; Bardak-Ozcem S; Turhan T; Arda B; Ruksen M; Pullukcu H; Aydemir S; Dalbasti T; Yurtseven T; Sipahi H; Zileli M; Ulusoy S
    Surg Infect (Larchmt); 2013 Aug; 14(4):357-62. PubMed ID: 23672240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials.
    An MM; Shen H; Zhang JD; Xu GT; Jiang YY
    Int J Antimicrob Agents; 2013 May; 41(5):426-33. PubMed ID: 23537580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of telavancin and vancomycin for treatment of methicillin-resistant Staphylococcus aureus infections: A meta-analysis.
    Liu Y; Wang J
    Int J Clin Pharmacol Ther; 2017 Nov; 55(11):839-845. PubMed ID: 28793957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
    J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
    Sakoulas G
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):813-5. PubMed ID: 19194364
    [No Abstract]   [Full Text] [Related]  

  • 40. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
    Pan KM; Wu Y; Chen C; Chen ZZ; Xu JA; Cao L; Xu Q; Wu W; Dai PF; Li XY; Lv QZ
    Br J Clin Pharmacol; 2018 Aug; 84(8):1706-1718. PubMed ID: 29607531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.